Literature DB >> 21809345

Differential contribution of SLC26A9 to Cl(-) conductance in polarized and non-polarized epithelial cells.

Jiraporn Ousingsawat1, Rainer Schreiber, Karl Kunzelmann.   

Abstract

SLC26 proteins function as anion exchangers and Cl(-) channels. SLC26A9 has been proposed to be a constitutively active and CFTR-regulated anion conductance in human bronchial epithelia. This positive interaction between two Cl(-) channels has been questioned by others and evidence has been provided that CFTR rather inhibits the transport activity of SLC26A9. We therefore examined the functional interaction between CFTR and SLC26A9 in polarized airway epithelial cells and in non-polarized HEK293 cells expressing CFTR and SLC26A9. We found that SLC26A9 provides a constitutively active basal Cl(-) conductance in polarized grown CFTR-expressing CFBE airway epithelial cells, but not in cells expressing F508del-CFTR. In polarized CFTR-expressing cells, SLC26A9 also contributes to both Ca(2+) - and CFTR-activated Cl(-) secretion. In contrast in non-polarized HEK293 cells co-expressing CFTR/SLC26A9, the baseline Cl(-) conductance provided by SLC26A9 was inhibited during activation of CFTR. SLC26A9 and CFTR behave differentially in polarized and non-polarized cells, which may explain earlier conflicting data.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21809345     DOI: 10.1002/jcp.22967

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9.

Authors:  Carol A Bertrand; Shalini Mitra; Sanjay K Mishra; Xiaohui Wang; Yu Zhao; Joseph M Pilewski; Dean R Madden; Raymond A Frizzell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-30       Impact factor: 5.464

Review 2.  Recent advances in developing therapeutics for cystic fibrosis.

Authors:  Lisa J Strug; Anne L Stephenson; Naim Panjwani; Ann Harris
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

3.  Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.

Authors:  Weili Li; David Soave; Melissa R Miller; Katherine Keenan; Fan Lin; Jiafen Gong; Theodore Chiang; Anne L Stephenson; Peter Durie; Johanna Rommens; Lei Sun; Lisa J Strug
Journal:  Hum Genet       Date:  2013-09-22       Impact factor: 4.132

4.  SLC26A9 is selected for endoplasmic reticulum associated degradation (ERAD) via Hsp70-dependent targeting of the soluble STAS domain.

Authors:  Patrick G Needham; Jennifer L Goeckeler-Fried; Casey Zhang; Zhihao Sun; Adam R Wetzel; Carol A Bertrand; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2021-12-22       Impact factor: 3.857

5.  Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence.

Authors:  Ximin Chi; Xueqin Jin; Yun Chen; Xiaoli Lu; Xinyu Tu; Xiaorong Li; Yuanyuan Zhang; Jianlin Lei; Jing Huang; Zhuo Huang; Qiang Zhou; Xiaojing Pan
Journal:  Cell Discov       Date:  2020-08-10       Impact factor: 10.849

Review 6.  The SLC26 gene family of anion transporters and channels.

Authors:  Seth L Alper; Alok K Sharma
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

7.  Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.

Authors:  Anh-Thu N Lam; Melis A Aksit; Briana Vecchio-Pagan; Celeste A Shelton; Derek L Osorio; Arianna F Anzmann; Loyal A Goff; David C Whitcomb; Scott M Blackman; Garry R Cutting
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

8.  Loss of Slc26a9 anion transporter alters intestinal electrolyte and HCO3(-) transport and reduces survival in CFTR-deficient mice.

Authors:  Xuemei Liu; Taolang Li; Brigitte Riederer; Henrike Lenzen; Lisa Ludolph; Sunil Yeruva; Biguang Tuo; Manoocher Soleimani; Ursula Seidler
Journal:  Pflugers Arch       Date:  2014-06-27       Impact factor: 3.657

9.  Genetic modifiers of cystic fibrosis-related diabetes.

Authors:  Scott M Blackman; Clayton W Commander; Christopher Watson; Kristin M Arcara; Lisa J Strug; Jaclyn R Stonebraker; Fred A Wright; Johanna M Rommens; Lei Sun; Rhonda G Pace; Sarah A Norris; Peter R Durie; Mitchell L Drumm; Michael R Knowles; Garry R Cutting
Journal:  Diabetes       Date:  2013-05-13       Impact factor: 9.461

Review 10.  Novel Roles for Chloride Channels, Exchangers, and Regulators in Chronic Inflammatory Airway Diseases.

Authors:  Monica Sala-Rabanal; Zeynep Yurtsever; Kayla N Berry; Tom J Brett
Journal:  Mediators Inflamm       Date:  2015-11-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.